Key result
EPOS-CC score outperforms UICC stage in predicting 5-year overall survival after colorectal cancer surgery.
Why the study?
Previous surgical audits focused on short-term outcomes after colorectal cancer surgery, lacking evaluation of long-term postoperative survival.
Does the EPOS-CC score predict 5-year overall survival better than UICC stage in patients undergoing colorectal cancer surgery?
Cohort (n=889)
Yes
Does the EPOS-CC score predict 5-year overall survival better than UICC stage in patients undergoing colorectal cancer surgery?
The EPOS-CC score, which integrates physiological and tumor-related variables, is superior to the UICC stage in predicting 5-year overall survival after colorectal cancer surgery.
BACKGROUND: Surgical audit is an essential task for the estimation of postoperative outcome and comparison of quality of care. Previous studies on surgical audits focused on short-term outcomes, such as postoperative mortality. We propose a surgical audit evaluating long-term outcome following colorectal cancer surgery. The predictive model for this audit is designated as 'Estimation of Postoperative Overall Survival for Colorectal Cancer (EPOS-CC)'. METHODS: Thirty-one tumor-related and physiological variables were prospectively collected in 889 patients undergoing elective resection for colorectal cancer between April 2005 and April 2007 in 16 Japanese hospitals. Postoperative overall survival was assessed over a 5-years period. The EPOS-CC score was established by selecting significant variables in a uni- and multivariate analysis and allocating a risk-adjusted multiplication factor to each variable using Cox regression analysis. For validation, the EPOS-CC score was compared to the predictive power of UICC stage. Inter-hospital variability of the observed-to-estimated 5-years survival was assessed to estimate quality of care. RESULTS: Among the 889 patients, 804 (90%) completed the 5-years follow-up. Univariate analysis displayed a significant correlation with 5-years survival for 14 physiological and nine tumor-related variables (p < 0.005). Highly significant p-values below 0.0001 were found for age, ASA score, severe pulmonary disease, respiratory history, performance status, hypoalbuminemia, alteration of hemoglobin, serum sodium level, and for all histological variables except tumor location. Age, TNM stage, lymphatic invasion, performance status, and serum sodium level were independent variables in the multivariate analysis and were entered the EPOS-CC model for the prediction of survival. Risk-adjusted multiplication factors between 1.5 (distant metastasis) and 0.16 (serum sodium level) were accorded to the different variables. The predictive power of EPOS-CC was superior to the one of UICC stage; area under the curve 0.87, 95% CI 0.85-0.90 for EPOS-CC, and 0.80, 0.76-0.83 for UICC stage, p < 0.001. Quality of care did not differ between hospitals. CONCLUSIONS: The EPOS-CC score including the independent variables age, performance status, serum sodium level, TNM stage, and lymphatic invasion is superior to the UICC stage in the prediction of 5-years overall survival. This higher accuracy might be explained by the inclusion of physiological factors, thus also taking non-tumor-associated deaths into account. Furthermore, EPOS-CC score may compare quality of care among different institutions. Future studies are necessary to further evaluate this score and help improving the prediction of long-term survival following colorectal cancer surgery.
No takes yet. Share an insight, caveat, or question.
Haga et al. (2015) conducted a cohort in Colorectal cancer (n=889). EPOS-CC score vs. UICC stage was evaluated on Prediction of 5-years overall survival (AUC 0.87, 95% CI 0.85-0.90, p=< 0.001). The EPOS-CC score was superior to the UICC stage in predicting 5-year overall survival following colorectal cancer surgery (AUC 0.87 vs 0.80; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: